Aims To determine whether lean body mass (LBM), a possible surrogate of liver and kidney volumes, correlates with hepatic and renal drug clearances. Methods Twenty-one disease-free patients with a history of cancer and with normal hepatic and renal function were studied. Salivary pharmacokinetics of oral antipyrine (1200 mg ) and 24 h creatinine clearance were determined following the determination of LBM by dual energy X-ray absorptiometry and the determination of liver and kidney volumes by helical CT scanning. Stepwise multiple regression analysis, incorporating the independent variables of age, height, weight, sex, BSA, LBM, alcohol consumption, smoking status and liver volume and the dependent variable antipyrine clearance, indicated that LBM was the only independent correlate of antipyrine clearance. A stepwise multiple regression analysis with kidney volume in the independent variables, and creatinine clearance as dependent variable, showed that kidney volume and age were the only independent correlates of creatinine clearance. A nomogram using serum creatinine and LBM was comparable with the Cockcroft and Gault nomogram in calculating creatinine clearance.
Introduction hepatic blood flow are functions of liver volume, hepatic drug clearance might be expected to be a function of liver There is a wide variation in drug clearance among individuals and our ability to predict individual drug clearance is limvolume. Evidence to support this has been found with antipyrine; however, drug metabolising activity g −1 liver is ited. Numerous attempts have been made to predict drug clearance from anthropometric characteristics but it remains also an important determinant of antipyrine elimination [14] [15] [16] [17] . Similarly, the number of nephrons, and therefore unclear which of these parameters is most useful [1] [2] [3] [4] . Estimates of body size have been most commonly used, in glomerular filtration rate, can be related to renal volume [18] . For many drugs eliminated predominantly by the liver, particular total body weight (TBW) and body surface area (BSA) [2, [4] [5] [6] [7] [8] [9] [10] . It has been suggested that lean body mass there is a correlation between systemic drug clearance and LBM [3] . It has been postulated that this correlation may be (LBM) may be more appropriate than TBW or BSA for individualising drug dosage [3, 11] . LBM consists of body due to the presence of a direct relationship between liver volume and LBM, since the liver is part of the lean cell mass, extracellular water and nonfat connective tissue and is essentially fat-free mass, but includes the fat in cell compartment [3] . Whether such a relationship exists is not known. Limited data suggest that LBM may be a useful membranes [12] . It is within the body cell mass, which is the major component of LBM, that over 99% of the body's predictor of creatinine clearance [19] . This also points to the possibility of an association between kidney volume and metabolic processes takes place [13] .
The main organs responsible for drug elimination are the LBM because the kidney is also part of the lean compartment.
In the current study we have examined the ability of
Correspondence: Dr Denis J. Morgan, Department of Pharmaceutics, Monash predicts hepatic and renal clearances by virtue of LBM being Centre. Prior to antipyrine administration, a saliva sample was taken. This was done by subjects first rinsing their a surrogate measurement of liver and kidney volumes, we have determined the relationship between hepatic and renal mouth with water and then chewing a piece of Parafilm (American Can Company, Greenwich, CT), to stimulate volumes and LBM. saliva flow. The saliva was then deposited into a plastic vial and stored at −20°C until analysed. Once the predose Methods saliva sample was taken 1200 mg antipyrine was administered orally. The antipyrine dose, in two hard gelatin capsules, Patients each containing 600 mg antipyrine, was administered orally Twenty-one patients (14 male, 7 female, median age 63 with 100 ml of water. Patients were than asked to sample years, range 25-76 years), with a history of cancer but no their own saliva at 3, 5, 8, 24 and 32 h after administration evidence of metastatic disease, who were presenting for a of antipyrine, in the same way as the predose sample. Of routine CT scan as part of their ongoing assessment, the patients entered, four patients (two males and two participated in the study. One patient was a smoker. All females) did not take the 1200 mg dose of antipyrine because patients had no known heart, liver or kidney disease detected they had difficulty swallowing or withdrew from the study. on clinical examination or biochemical and haematological screening and all had a normal ECG and chest X-ray. They
Creatinine clearance Creatinine clearance was determined had received no chemotherapy or radiation therapy, or any using a 24 h urine collection and serum creatinine concenmedication known to affect hepatic or renal drug elimination tration. Patients were responsible for the collection of their for 6 months prior to entering the study. The patients own urine. When collecting their urine, patients were consented in writing to participate in the study on the basis instructed to discard the first specimen, and then to collect of written and oral information, and the study was approved all urine for a period of 24 h into the plastic bottle provided. by the human ethics committee of the Austin and
Patients were asked to bring the urine to the clinic within Repatriation Medical Centre.
24 h of finishing the collection. A blood sample was then taken for determination of serum creatinine concentration.
Study procedure

Determination of liver and kidney volumes Liver and kidney
Analytical methods volumes were determined by helical CT scanning with a Antipyrine Antipyrine concentrations in saliva were assayed Siemens Somatom Plus S whole-body CT scanner. The by an h.p.l.c. method described previously [24] . At scans were performed as part of the patients' clinical concentrations of 2.5, 12.5 and 25 mg ml −1 intra-assay and assessment for the presence of metastatic disease. A preconinterassay coefficients of variation were less than 3.4 and trast scan and a postcontrast scan were performed. Both of 6.0%, respectively, and accuracy was within 3%. these scans were used to evaluate the patients' disease. Only the precontrast helical CT scan was used to determine the organ volume. The total kidney volume for patient 1 was
Creatinine Urine and serum creatinine concentrations were unavailable due to an incomplete CT scan. We have shown determined by autoanalyser at the Department of previously that the accuracy and bias for the determination Biochemistry, Austin and Repatriation Medical Centre. The of liver and kidney volumes with this method are 95.6 and coefficients of variation for the measurement of serum 3.1%, respectively [20] .
creatinine concentration (at 0.13 mmol l −1 ) and urine creatinine concentration (at 7.4 mmol l −1 ) were 3.9% and Determination of lean body mass LBM was determined by 3%, respectively. dual energy X-ray absorptiometry (DEXA). This technique is based on the assumption that the body consists of two Data analysis main compartments, bone and soft tissue. These two compartments are distinguished by measuring the photon Area under the salivary antipyrine concentration vs time attenuation at two discrete photon energies, which distingucurve (AUC) was determined by the trapezoidal rule, with ishes between fat, fat-free mass and bone. The radiation extrapolation to infinity. Antipyrine clearance was calculated exposure is one-tenth that of a standard chest X-ray. DEXA as dose/AUC, assuming complete absorption. Creatinine has an accuracy for the determination of LBM of greater clearance was determined from serum creatinine and urinary than 98%, with a coefficient of variation of between 1 and creatinine excretion rate and was also predicted from the 3% [21, 22] .
Cockcroft & Gault formula which uses serum creatinine, TBW, sex and age [25] . Relationships among pharmacoDetermination of total body surface area BSA was determined kinetic parameters and patient variables were examined by using the Dubois Table 1 . There was Discussion large interpatient variation in the clearance of antipyrine, which ranged from 680 to 3300 ml h −1 and in creatinine It has been postulated that the correlation between hepatic clearance and LBM observed with many drugs may be due clearance, which ranged from 42 to 222 ml min −1 (Table 1) .
Liver volume correlated with LBM ( Figure 1a, (Table 2) and there was only a weak correlation between liver volume and LBM (Figure 1a) . By contrast, with LBM ( Figure 2a (Figure 1b) , as reported previously [14, 26] . Therefore, 0.03). There was no correlation between liver or kidney volume and age.
other physiological factors are likely to be more important than liver volume in accounting for the association between To investigate possible correlates of antipyrine clearance, stepwise multiple regression analysis was conducted, includantipyrine clearance and LBM. Previous investigations of the relationship between antiing age, height, weight, sex, BSA, LBM, alcohol consumption, smoking status, and liver volume. LBM was the only pyrine clearance and liver volume have also found only a weak correlation (r 2 =0.29-0.48) [14] [15] [16] [17] . The conclusion significant correlate of antipyrine clearance (Table 2) . Age was associated with antipyrine clearance in a univariate (r 2 = from these investigations was that interpatient variability in hepatic enzyme activity is a more important determinant of 0.25, P=0.04) but not in a multivariate analysis (Table 2) .
There was a univariate correlation between creatinine antipyrine clearance than liver volume. It should be noted, however, that these studies [14] [15] [16] (Table 3) , whether or not the outlier (subject 4, Table 1 ) was included in the difference in methodology may account for the difference in correlation between antipyrine clearance and liver volume analysis. Using multiple linear regression analysis two models were developed which relate creatinine clearance to LBM in the present study. As there was no correlation between clearance and liver volume for antipyrine, a drug with either alone or in combination with serum creatinine (Table 4) . Model 2 was in better agreement with the extremely broad isoform specificity [28], then there is probably little chance of a correlation with probes which measured creatinine clearance (r 2 =0.53) than model 1 (r 2 = 0.28) and similar agreement with the creatinine clearance reflect specific isoform activity. In the present study, antipyrine clearance decreased with (Table 3 ). The good correlation between kidney volume and LBM suggests therefore that LBM does act as a surrogate age, as found by previous investigators [16, 17] . However, in this study age was not an independent correlate of marker of kidney volume in the correlation with creatinine clearance. The correlation between creatinine clearance and antipyrine clearance, perhaps in part because of the smaller sample size.
kidney volume was probably due to the fact that creatinine is mainly cleared by glomerular filtration and the number of Stepwise multiple linear regression analysis revealed that overall interpatient differences in age and kidney volume glomeruli present is proportional to kidney volume [18] . It has been suggested by Hallynck et al.
[29] that LBM were the main sources of variability in creatinine clearance between clearance and TBW requires further investigation.
In conclusion, the reason for the relationship between uses serum creatinine concentration, age and TBW, was 243-247. found to account for 49% of the variability of measured creatinine clearance. Of the two predictive models developed
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